Xtant Medical Holdings, Inc. (XTNT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 20.88M | 32.36M | 33.26M | 35.41M | 32.9M | 31.51M | 27.94M | 29.94M | 27.87M | 28.11M | 25.02M | 20.23M |
| Revenue Growth % | -36.53% | 2.68% | 19.04% | 18.26% | 18.05% | 12.11% | 11.66% | 48% | 55.34% | 84.07% | 73% | 32.43% |
| Cost of Goods Sold | 8.91M | 14.6M | 11.26M | 11.13M | 12.66M | 15.49M | 11.63M | 11.36M | 10.57M | 10.97M | 9.69M | 7.77M |
| COGS % of Revenue | 42.68% | 45.13% | 33.87% | 31.42% | 38.48% | 49.15% | 41.63% | 37.94% | 37.93% | 39.03% | 38.71% | 38.42% |
| Gross Profit | 11.97M | 17.75M | 21.99M | 24.28M | 20.24M | 16.02M | 16.31M | 18.58M | 17.3M | 17.14M | 15.33M | 12.46M |
| Gross Margin % | 57.32% | 54.87% | 66.13% | 68.58% | 61.52% | 50.85% | 58.37% | 62.06% | 62.07% | 60.97% | 61.29% | 61.58% |
| Gross Profit Growth % | -40.86% | 10.8% | 34.86% | 30.69% | 17% | -6.49% | 6.35% | 49.15% | 64.22% | 106.32% | 94.2% | 48.78% |
| Operating Expenses | 14.89M | 18.7M | 19.45M | 19.66M | 19.18M | 17.91M | 20.08M | 21.53M | 20.77M | 20.94M | 18.72M | 13.85M |
| OpEx % of Revenue | 71.32% | 57.79% | 58.49% | 55.52% | 58.29% | 56.82% | 71.89% | 71.9% | 74.52% | 74.51% | 74.82% | 68.46% |
| Selling, General & Admin | 14.46M | 18.24M | 18.82M | 19.09M | 18.74M | 17.38M | 19.38M | 20.89M | 20.25M | 20.45M | 18.23M | 13.67M |
| SG&A % of Revenue | 69.23% | 56.37% | 56.58% | 53.92% | 56.94% | 55.16% | 69.38% | 69.77% | 72.63% | 72.76% | 72.86% | 67.57% |
| Research & Development | 435K | 459K | 634K | 566K | 443K | 522K | 701K | 636K | 527K | 492K | 490K | 180K |
| R&D % of Revenue | 2.08% | 1.42% | 1.91% | 1.6% | 1.35% | 1.66% | 2.51% | 2.12% | 1.89% | 1.75% | 1.96% | 0.89% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.92M | -944K | 2.54M | 4.62M | 1.06M | -1.88M | -3.78M | -2.95M | -3.47M | -3.81M | -3.38M | -1.39M |
| Operating Margin % | -14% | -2.92% | 7.64% | 13.06% | 3.23% | -5.97% | -13.52% | -9.84% | -12.45% | -13.54% | -13.53% | -6.88% |
| Operating Income Growth % | -374.98% | 49.84% | 167.28% | 256.96% | 130.63% | 50.55% | -11.58% | -111.79% | -120.18% | -120.77% | -78.16% | -7% |
| EBITDA | -2.39M | 875K | 3.7M | 5.79M | 2.14M | -734K | -2.7M | -1.95M | -2.46M | -2.79M | -2.5M | -588K |
| EBITDA Margin % | -11.44% | 2.7% | 11.13% | 16.36% | 6.49% | -2.33% | -9.68% | -6.51% | -8.84% | -9.92% | -10% | -2.91% |
| EBITDA Growth % | -211.79% | 219.21% | 236.91% | 397.38% | 186.69% | 73.68% | -8.07% | -231.29% | -123.48% | -99.07% | -63.74% | 40.12% |
| D&A (Non-Cash Add-back) | 534K | 1.82M | 1.16M | 1.17M | 1.07M | 1.15M | 1.07M | 998K | 1M | 1.02M | 883K | 803K |
| EBIT | -2.92M | 2.32M | 2.47M | 4.81M | 1.08M | -2.01M | -3.76M | -2.83M | -3.5M | -2.91M | 7.69M | -1.39M |
| Net Interest Income | -380K | -624K | -904K | -1M | -1.04M | -1.13M | -1.2M | -992K | -835K | -802K | -712K | -786K |
| Interest Income | 219K | 94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16K | 48K | 0 |
| Interest Expense | 599K | 718K | 904K | 1M | 1.04M | 1.13M | 1.2M | 992K | 835K | 818K | 760K | 786K |
| Other Income/Expense | -139K | 2.54M | -976K | -819K | -1.03M | -1.26M | -1.19M | -879K | -862K | 80K | 10.32M | -786K |
| Pretax Income | -3.06M | 1.6M | 1.56M | 3.81M | 33K | -3.14M | -4.96M | -3.83M | -4.33M | -3.73M | 6.93M | -2.18M |
| Pretax Margin % | -14.66% | 4.94% | 4.71% | 10.75% | 0.1% | -9.98% | -17.76% | -12.77% | -15.54% | -13.26% | 27.7% | -10.76% |
| Income Tax | 27K | 1.54M | 257K | 255K | -25K | 21K | 62K | 36K | 68K | 577K | -2.3M | 13K |
| Effective Tax Rate % | -0.88% | 96.43% | 16.42% | 6.7% | -75.76% | -0.67% | -1.25% | -0.94% | -1.57% | -15.49% | -33.18% | -0.6% |
| Net Income | -3.09M | 57K | 1.31M | 3.55M | 58K | -3.17M | -5.02M | -3.86M | -4.4M | -4.3M | 9.23M | -2.19M |
| Net Margin % | -14.79% | 0.18% | 3.93% | 10.03% | 0.18% | -10.04% | -17.98% | -12.89% | -15.79% | -15.31% | 36.9% | -10.82% |
| Net Income Growth % | -5425.86% | 101.8% | 126.04% | 191.95% | 101.32% | 26.45% | -154.43% | -76.3% | -111.74% | -94.79% | 492.31% | -28.07% |
| Net Income (Continuing) | -3.09M | 57K | 1.31M | 3.55M | 58K | -3.17M | -5.02M | -3.86M | -4.4M | -4.3M | 9.23M | -2.19M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.02 | 0.00 | 0.01 | 0.02 | 0.00 | -0.02 | -0.04 | -0.03 | -0.03 | -0.03 | 0.07 | -0.02 |
| EPS Growth % | - | 101.75% | 123.66% | 180.74% | 101.18% | 31.12% | -154.71% | -48% | -76.96% | -62.25% | 369.84% | -2.04% |
| EPS (Basic) | -0.02 | 0.00 | 0.01 | 0.03 | 0.00 | -0.02 | -0.04 | -0.03 | -0.03 | -0.03 | 0.07 | -0.02 |
| Diluted Shares Outstanding | 150.46M | 150.46M | 148.57M | 148.57M | 143.34M | 138.98M | 135.1M | 130.27M | 130.2M | 130.02M | 135.66M | 108.9M |
| Basic Shares Outstanding | 139.83M | 139.83M | 139.31M | 139.31M | 143.56M | 138.98M | 135.1M | 130.27M | 130.2M | 130.02M | 128.14M | 108.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |